The Effects of Tetanus Vaccination on Mediators of Autoimmunity in Patients with Multiple Sclerosis.

Trial Profile

The Effects of Tetanus Vaccination on Mediators of Autoimmunity in Patients with Multiple Sclerosis.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 May 2012

At a glance

  • Drugs DT-poliovirus vaccine (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top